From the Cell Therapy Systems (CTS™) line of products, B-27® Supplement, XenoFree CTS™, is B-27® Serum-Free Supplement formulated with only recombinant or humanized components. Designed with the translational stem cell researcher in mind, this B-27® supplement can be used to support induction of human neural stem cells (hNSCs) from pluripotent stem cells (PSCs), expansion of hNSCs, differentiation of hNSCs, and maintenance of mature differentiated neurons in culture.
• Validated—designed for use with the CTS™ line of neural cell culture products
• High performance—performs equivalently to B-27® Serum-Free Supplement, the gold standard for neural cell culture
• Expanded use—for research use or manufacturing of cell-, gene-, or tissue-based productsEnd-to-End Solution
When used in conjunction with other CTS™ neural cell culture products
, B-27® Supplement, XenoFree CTS™, has been validated for use in all four major steps of neural stem cell culture: induction, expansion, differentiation, and maintenance of mature, differentiated neurons (Figure 1).B-27® Brand Quality and Reliability
Using advanced manufacturing methods and the highest quality raw materials, B-27® Supplement, XenoFree CTS™, performs equivalently to B-27® Serum-Free Supplement (Figure 2).Gibco® CTS Promise
Gibco® CTS™ brand products comprise a broad array of products for use in cell therapy research applications. CTS™ products are manufactured following GMP 21 CFR Part 864, subpart C, and ISO 9001/13485 and deliver reduced burden in qualifying reagents when transitioning from the research bench to the clinic. Specific intended-use statements, full documentation traceability, and convenient access to our Drug Master File (DMF) are available, where applicable.